Stephen Mark Cone - 13 May 2025 Form 4 Insider Report for biote Corp. (BTMD)

Role: Director
Signature: /s/ Marybeth Conlon, as Attorney-in-Fact for Mark Cone
Issuer symbol: BTMD
Transactions as of: 13 May 2025
Net transactions value: $0
Form type: 4
Filing time: 14 May 2025, 19:42:02 UTC
Previous filing: 18 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cone Stephen Mark	Director	C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING	/s/ Marybeth Conlon, as Attorney-in-Fact for Mark Cone	14 May 2025	0001931328

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTMD	Deferred Settlement RSU	Award	$0	+17,989	+88%	$0.000000	38,341	13 May 2025	Class A Common Stock	17,989		Direct	F1, F2
transaction	BTMD	Stock Option (Right to Buy)	Award	$0	+104,547		$0.000000	104,547	13 May 2025	Class A Common Stock	104,547	$3.91	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
F2	The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the date of the Reporting Person's separation from service.
F3	All shares subject to the option award shall vest on the earlier of May 13, 2026 or the day prior to the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.